Medicare Enrolled

Dr. Vijaykumar Gandhi, M.D.

Medical Oncology · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
333 COTTMAN AVE, Philadelphia, PA 19111
2157282500
Registered in NPPES since 2006
NPI: 1619930617 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gandhi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gandhi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gandhi

Dr. Vijaykumar Gandhi is a medical oncology specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gandhi performed 617 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Gandhi received a total of $7,204 from 54 pharmaceutical and/or device companies across 384 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gandhi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 38% volume in PA $7,204 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
617
Medicare services
Top 38% in PA for medical oncology
Not available
Unique patients (not deduplicated)
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
216 $74 $249
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
119 $41 $120
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
87 $143 $625
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
84 $66 $221
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
56 $100 $418
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
41 $55 $162
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
14 $103 $351
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,204
Total received (2018-2024)
Avg $1,029/year across 7 years
Top 35% in PA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
384
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,223
2023
$2,012
2022
$1,647
2021
$17
2020
$153
2019
$632
2018
$520

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$296
Daiichi Sankyo Inc.
$179
Janssen Pharmaceuticals, Inc
$157
Janssen Biotech, Inc.
$132
Teva Pharmaceuticals USA, Inc.
$123
ABBVIE INC.
$113
Celgene Corporation
$103
Gilead Sciences, Inc.
$102
Eisai Inc.
$94
E.R. Squibb & Sons, L.L.C.
$78
Lilly USA, LLC
$70
PFIZER INC.
$69
Exelixis Inc.
$66
Immunocore Limited
$65
Merck Sharp & Dohme LLC
$57
Bayer Healthcare Pharmaceuticals Inc.
$57
Novocure Inc.
$56
Tempus AI, Inc
$52
Genmab U.S., Inc.
$51
Stemline Therapeutics Inc.
$51
SOBI, INC
$33
GlaxoSmithKline, LLC.
$33
Astellas Pharma US Inc
$30
Incyte Corporation
$30
Adaptive Biotechnologies Corporation
$25
Rigel Pharmaceuticals, Inc.
$23
Novartis Pharmaceuticals Corporation
$18
Deciphera Pharmaceuticals Inc.
$16
TerSera Therapeutics LLC
$16
Regeneron Healthcare Solutions, Inc.
$15
Mirati Therapeutics, Inc.
$14
Top 3 companies account for 28.5% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$743
AstraZeneca Pharmaceuticals LP
$503
Janssen Biotech, Inc.
$440
E.R. Squibb & Sons, L.L.C.
$429
Novartis Pharmaceuticals Corporation
$404
ABBVIE INC.
$361
Celgene Corporation
$355
Eisai Inc.
$314
Merck Sharp & Dohme LLC
$280
PFIZER INC.
$211
Gilead Sciences, Inc.
$208
Lilly USA, LLC
$202
Incyte Corporation
$181
Janssen Pharmaceuticals, Inc
$157
Astellas Pharma US Inc
$140
Kowa Pharmaceuticals America, Inc.
$124
Teva Pharmaceuticals USA, Inc.
$123
SK Life Science, Inc.
$123
Exelixis Inc.
$123
Takeda Pharmaceuticals U.S.A., Inc.
$119
Bayer Healthcare Pharmaceuticals Inc.
$110
Seagen Inc.
$103
SANOFI-AVENTIS U.S. LLC
$99
Genmab U.S., Inc.
$95
Stemline Therapeutics Inc.
$88
Pharmacyclics LLC, An AbbVie Company
$80
MorphoSys, US Inc.
$77
GENZYME CORPORATION
$67
Pharmacyclics LLC, an AbbVie Company
$66
Immunocore Limited
$65
Amgen Inc.
$64
Foundation Medicine, Inc.
$63
Genentech USA, Inc.
$61
Kite Pharma, Inc.
$61
EISAI INC.
$57
Novocure Inc.
$56
Tempus AI, Inc
$52
GlaxoSmithKline, LLC.
$49
SOBI, INC
$49
Bayer HealthCare Pharmaceuticals Inc.
$46
Rigel Pharmaceuticals, Inc.
$34
Regeneron Healthcare Solutions, Inc.
$29
Adaptive Biotechnologies Corporation
$25
Aadi Bioscience, Inc.
$17
TAIHO ONCOLOGY, INC.
$17
Deciphera Pharmaceuticals Inc.
$16
Puma Biotechnology, Inc.
$16
TerSera Therapeutics LLC
$16
ARRAY BIOPHARMA INC
$16
EMD Serono, Inc.
$15
TESARO, Inc.
$14
Mirati Therapeutics, Inc.
$14
Alexion Pharmaceuticals, Inc.
$13
AMAG Pharmaceuticals, Inc.
$13
Top 3 companies account for 23.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AIRSUPRA · ALUNBRIG · AUGTYRO · AVYCAZ · Austedo XR · BOSULIF · Bavencio · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · ENHERTU · ERBITUX · ERLEADA · Enhertu · Epkinly · FERAHEME · FOUNDATIONONE · FOUNDATIONONE CDX · Fyarro · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUPRON DEPOT · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · NINLARO · Nerlynx · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · Optune · Orserdu · PADCEV · PIQRAY · PROMACTA · Padcev · Pomalyst · QINLOCK · REBLOZYL · Revlimid · Rezlidhia · SANDOSTATIN LAR · SCEMBLIX · Seglentis · Stivarga · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIVDAK · Tivdak · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VPRIV · VRAYLAR · Venclexta · XALKORI · XARELTO · XCOPRI · XT CDX · Xospata · Xtandi · ZEJULA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical oncology specialist in Philadelphia?
Compare medical oncologists in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists in nearby ZIP areas
117
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
NAZARETH HOSPITAL
1.8 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gandhi is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gandhi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gandhi performed 216 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gandhi receive payments from pharmaceutical companies?
Yes. Dr. Gandhi received a total of $7,204 from 54 companies across 384 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gandhi's costs compare to other medical oncologists in Philadelphia?
Dr. Gandhi's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gandhi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →